Ketasma Tablet contains Ketotifen 1 mg, an antihistamine with mast cell stabilizing properties, primarily indicated for the prevention and management of allergic conditions such as asthma, allergic rhinitis, and chronic urticaria. Ketotifen acts by inhibiting the release of histamine and other mediators from mast cells, thereby reducing allergic inflammation and hypersensitivity reactions. It is effective in controlling symptoms like wheezing, nasal congestion, itching, and hives. Ketasma is typically administered orally, with dosage tailored to patient age and clinical response. The medication is generally well tolerated; however, some patients may experience side effects including drowsiness, dry mouth, dizziness, or gastrointestinal discomfort. Caution is advised when used concomitantly with other central nervous system depressants. Ketasma should be used under medical supervision, especially in patients with hepatic or renal impairment. It is contraindicated in individuals with known hypersensitivity to Ketotifen or any tablet excipients. Regular monitoring and adherence to prescribed dosage enhance therapeutic outcomes. Ketasma Tablet offers a reliable option in the prophylactic treatment of allergic disorders, improving patient quality of life by mitigating recurrent allergic episodes and associated symptoms.